Data on Biogen's Alzheimer's drug raise more questions than answers

Data on Biogen's Alzheimer's drug raise more questions than answers

Detailed data on Biogen’s resurrected Alzheimer’s drug raise more questions than answers

By REBECCA ROBBINS AND MATTHEW HERPER

RUBY WALLAU FOR STAT

The drug maker argues that its mixed study results can be explained away by differences in whether patients got the highest dose of the medicine. 

READ MORE